• A 42-Year-Old Woman with Untreated Growth Hormone Insensitivity, Diabetic Retinopathy, and Gene Sequencing Identifies a Variant of Laron Syndrome
• A common human missense mutation of vesicle coat protein SEC23B leads to growth restriction and chronic pancreatitis in mice
• A novel heterozygous STAT5B variant in a patient with short stature and partial growth hormone insensitivity (GHI)
• A Novel, Heterozygous, de novo Splicing Variant Affecting the Intracellular Domain of the Growth Hormone Receptor, and Causing a Mild Short Stature
• A Recurrent Mutation in Growth Hormone Receptor (<em>GHR</em>) Gene Underlying Laron-type Dwarfism in a Pakistani Family
• A Recurrent Mutation in Growth Hormone Receptor (GHR) Gene Underlying Laron-type Dwarfism in a Pakistani Family
• A zebrafish model of growth hormone insensitivity syndrome with immune dysregulation 1 (GHISID1)
• About a Suggestive Association Between Fanconi Anemia and Laron Syndrome
• Adult patients with Laron syndrome tend to develop the metabolic syndrome
• Alterations in Stem Cell Populations in IGF-1 Deficient Pediatric Patients Subjected to Mecasermin (Increlex) Treatment
• An unusual brain lesion in a patient with Laron Syndrome
• Anti-Müllerian Hormone, Growth Hormone, and Insulin-Like Growth Factor 1 Modulate the Migratory and Secretory Patterns of GnRH Neurons
• Assessing insulin sensitivity and resistance in syndromes of severe short stature
• Branding of subjects affected with genetic syndromes of severe short stature in developing countries
• Cancer in Ecuadorian subjects with Laron syndrome (ELS)
• Cancer in GH excess and GH deficit
• Cancer in growth hormone excess and growth hormone deficit
• Cardiac examination in children with Laron syndrome undergoing mecasermin therapy
• Challenges in the care of individuals with severe primary insulin-like growth factor-I deficiency (SPIGFD): an international, multi-stakeholder perspective
• Changes in plasma amino acids metabolites, caused by long-term IGF-I deficiency, are reversed by IGF-I treatment - A pilot study
• Clinical profile of Laron dwarfism - experience from a tertiary care institute in Chennai
• Congenital IGF-1 deficiency protects from cancer: lessons from Laron syndrome
• Diagnosis of Laron syndrome using monoplex-polymerase chain reaction technology with a whole-genome amplification template: A case report
• Divergent metabolic phenotypes in two genetic syndromes of low insulin secretion
• Dominant-negative STAT5B mutations cause growth hormone insensitivity with short stature and mild immune dysregulation
• Effect of Growth Hormone Receptor Deficiency on Androgen-Associated Gene Expression of Hepatic Drug Metabolizing Enzymes and Drug Transporters in Pigs
• Effectiveness and safety of rhIGF1 therapy in patients with or without Laron syndrome
• Effects of GHR Deficiency and Juvenile Hypoglycemia on Immune Cells of a Porcine Model for Laron Syndrome
• Erratum: Laron syndrome
• Fanconi's anaemia & Laron syndrome: An enigma
• Fanconi's anaemia &amp; Laron syndrome: An enigma
• First use of gene therapy to treat growth hormone resistant dwarfism in a mouse model
• Focal Epilepsy in Individuals with Laron Syndrome
• Frequency and Predictive Factors of Hypoglycemia in Patients Treated With rhIGF-1: Data From the Eu-IGFD Registry
• From Churchill to Elephants: The Role of Protective Genes against Cancer
• From dwarves to giants: South American's contribution to the history of growth hormone and related disorders
• Functional changes of the liver in the absence of growth hormone (GH) action - Proteomic and metabolomic insights from a GH receptor deficient pig model
• Further Clinical Evidence for the Effect of IGF-1 on Hair Growth and Alopecia
• Genetic causes of growth hormone insensitivity beyond GHR
• Genetic Characterization of Short Stature Patients With Overlapping Features of Growth Hormone Insensitivity Syndromes
• Genetic Competencies for Effective Pediatric Endocrine Nursing Practice
• Genome-Wide Profiling of Laron Syndrome Patients Identifies Novel Cancer Protection Pathways
• GH-dependent growth of experimentally induced carcinomas in vivo
• Growth Hormone and the Human Hair Follicle
• Growth Hormone Deficiency: Health and Longevity
• Growth Hormone insensitivity (Laron syndrome): Report of a new family and review of Brazilian patients
• Growth hormone insensitivity and adipose tissue: tissue morphology and transcriptome analyses in pigs and humans
• Growth hormone modulates Trypanosoma cruzi infection in vitro
• Growth Hormone Receptor (GHR) 6Ω Pseudoexon Activation: a Novel Cause of Severe Growth Hormone Insensitivity
• Growth Hormone Receptor (Ghr) 6ω Pseudoexon Activation: A Novel Cause Of Severe Growth Hormone Insensitivity (Ghi)
• Growth hormone receptor deficiency in humans associates to obesity, increased body fat percentage, a healthy brain and a coordinated insulin sensitivity
• Growth hormone receptor knockout: Relevance to xenotransplantation
• Growth Hormone Receptor Mutations Related to Individual Dwarfism
• Growth Hormone's Links to Cancer
• High growth hormone serum partially protects mice against Trypanosoma cruzi infection
• Hormone resistance in children: what primary care physicians need to know
• Identification and <em>In Vitro</em> Functional Verification of Two Novel Mutations of <em>GHR</em> Gene in the Chinese Children with Laron Syndrome
• Identification and In Vitro Functional Verification of Two Novel Mutations of GHR Gene in the Chinese Children with Laron Syndrome
• Identification of nephronectin as a new target for IGF1 action
• Identification of UDP-Glucuronosyltransferase 2B15 (UGT2B15) as a Target for IGF1 and Insulin Action
• Identification of ZYG11A as a candidate IGF1-dependent proto-oncogene in endometrial cancer
• In Reference to Fanconi Anemia and Laron Syndrome
• Insights from the clinical phenotype of subjects with Laron syndrome in Ecuador
• Insulin-like growth factors and aging: lessons from Laron syndrome
• Invaluable Role of Consanguinity in Providing Insight into Paediatric Endocrine Conditions: Lessons Learnt from Congenital Hyperinsulinism, Monogenic Diabetes, and Short Stature
• Laron syndrome - A historical perspective
• Laron syndrome in three female siblings with the development of subclinical hypothyroidism and dyslipidemia in one case: first report of a Syrian family
• Laron syndrome related to homozygous growth hormone receptor c.784&gt;C mutation in a patient with hypoplastic pulmonary arteries
• Laron syndrome related to homozygous growth hormone receptor c.784>C mutation in a patient with hypoplastic pulmonary arteries
• Laron Syndrome Research Paves the Way for New Insights in Oncological Investigation
• Laron Syndrome: A Tale of Two Siblings
• Letters to the Editor: Why are Children with Klinefelter Syndrome Tall?
• Long-Term IGF1 Stimulation Leads to Cellular Senescence via Functional Interaction with the Thioredoxin-Interacting Protein, TXNIP
• Marjolin's Ulcer in Laron Syndrome - an Unexpected Combination: A Case Report
• MECHANISMS IN ENDOCRINOLOGY: Transient juvenile hypoglycemia in growth hormone receptor deficiency - mechanistic insights from Laron syndrome and tailored animal models
• Mesenchymal growth hormone receptor deficiency leads to failure of alveolar progenitor cell function and severe pulmonary fibrosis
• Metabolomics changes in patients with PAPP-A2 deficiency in response to rhIGF1 treatment
• MicroRNA 132-3p Is Upregulated in Laron Syndrome Patients and Controls Longevity Gene Expression
• Mild phenotype in two siblings with a missense GHR variant
• Mitochondrial Function Is Compromised in Cortical Bone Osteocytes of Long-Lived Growth Hormone Receptor Null Mice
• Mouse models of growth hormone insensitivity
• Musculoskeletal Effects of Altered GH Action
• Mutations of uncertain significance in heterozygous variants as a possible cause of severe short stature: a case report
• Normal or improved cardiovascular risk factors in IGF-I-deficient adults with growth hormone receptor deficiency
• Prevalence of diabetes among children treated with growth hormone in Israel
• Reporting a novel growth hormone receptor gene variant in an Iranian consanguineous pedigree with Laron syndrome: a case report
• Role of the GH-IGF1 axis on the hypothalamus-pituitary-testicular axis function: lessons from Laron syndrome
• Role of the GH-IGF1 system in progression of cancer
• Same Phenotype in Children with Growth Hormone Deficiency and Resistance
• Sequential measurements of IGF-I serum concentrations in adolescents with Laron syndrome treated with recombinant human IGF-I (rhIGF-I)
• Severe growth failure associated with a novel heterozygous nonsense mutation in the GHR transmembrane domain leading to elevated growth hormone binding protein
• Short stature related to Growth Hormone Insensitivity (GHI) in childhood
• Structural and proteomic repercussions of growth hormone receptor deficiency on the pituitary gland: Lessons from a translational pig model
• Systemic Deficiency of GHR in Pigs leads to Hepatic Steatosis via Negative Regulation of AHR Signaling
• The History of the Insulin-Like Growth Factor System
• The Olfactory Receptor Gene Product, OR5H2, Modulates Endometrial Cancer Cells Proliferation via Interaction with the IGF1 Signaling Pathway
• Therapeutic application of Sertoli cells for treatment of various diseases
• Therapy with recombinant human IGF-1 for children with primary insulin-like growth factor-I deficiency
• Toward gene therapy of Laron syndrome
• Treatment for Infertility in Laron Syndrome: A Case Report